2026-04-27 – Press Releases – www.prnewswire.com
– 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes. – Topline data from the Phase II study are expected in the third quarter of 2026. HONG KONG, April 27,…
Mon-Fri 10 am to 7 pm.
Warehouse: (No Walk-In)
Scommerce, 1 Buroh Crescent #03-01
Cogent 1.Logistics Hub S(627545)
Qxpress, 30 Tuas West Rd, level 5, S (638386)
Copyright © 2026 Buy Supplements Online all rights reserved.
All the content on this website, including medical opinion and any other health-related information, are solely to provide information only. Any information/statements on this blog are not intended to diagnose, treat, cure or prevent any disease, and should NOT be a substitute for health and medical advice that can be provided by your own physician/medical doctor. You should always consult a doctor before making any health or diet changes, especially any changes related to a specific diagnosis or condition.
